Most vulnerable often overlooked in clinical trials of new treatments for COVID-19

Retrieved on: 2021-02-03 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Most vulnerable often overlooked in clinical trials of new treatments for COVID-19. View article details on hiswai:

Excerpt

"Researchers, hospitals and pharmaceutical companies need to think hard about ... About the University of Chicago Medicine & Biological Sciences.

Article found on: www.eurekalert.org